Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of ApoB in lipid transport and metabolism of the apoB-containing lipoprotein.
about
Familial hypobetalipoproteinemia: a reviewReduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncationHepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying alleleAlterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion.In vivo MRS measurement of liver lipid levels in mice.Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein BApolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB)Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouseMonogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism.Lipoprotein metabolism in nonalcoholic fatty liver diseaseAmino acid sequences within the beta1 domain of human apolipoprotein B can mediate rapid intracellular degradation.Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.Hepatic triglyceride contents are genetically determined in mice: results of a strain survey.
P2860
Q28183795-84C0405C-778E-4790-AFD9-1B8CBBF6AA0CQ28508454-D326DC70-77E6-4A1C-A759-1B0EFD1B2C90Q28593031-F2002275-B9D5-4970-AA51-725A5CAA0B8CQ30439917-56C6083F-B572-4C25-AD17-15A5F1B7871CQ30924323-37A7F358-5958-4D9B-B406-DC63AA70C196Q33673712-4C798B22-87CA-4672-9F43-F0E9F8666694Q33858526-BAE29167-05E8-4F19-9251-95DE0A833737Q33863614-4B3D6F85-919B-4F30-BD70-8DF9A55FD2E8Q34074263-A999113B-C753-4A88-BF63-4F0AA521E1FCQ35751913-52B66D64-7017-40B2-9559-97BE99BD039DQ36359516-49037AF7-291B-4DF8-A216-DCE8C7F10743Q36682138-F692C7C1-A8B3-4CF5-A06C-70EEBA2B47F8Q40622275-B87C4A8A-DFE9-4138-B9EA-F253FD5AF6FEQ44300095-5B44251A-69E7-4CD0-9518-B7C3793DD934Q44766939-65D0040F-3D14-4360-9587-95FD444F7482Q45182803-2D5FC22D-3841-4CF8-BD1E-54B7B3FC0204
P2860
Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of ApoB in lipid transport and metabolism of the apoB-containing lipoprotein.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Hypobetalipoproteinemic mice w ...... e apoB-containing lipoprotein.
@en
Hypobetalipoproteinemic mice with a targeted apolipoprotein
@nl
type
label
Hypobetalipoproteinemic mice w ...... e apoB-containing lipoprotein.
@en
Hypobetalipoproteinemic mice with a targeted apolipoprotein
@nl
prefLabel
Hypobetalipoproteinemic mice w ...... e apoB-containing lipoprotein.
@en
Hypobetalipoproteinemic mice with a targeted apolipoprotein
@nl
P2093
P2860
P356
P1476
Hypobetalipoproteinemic mice w ...... e apoB-containing lipoprotein.
@en
P2093
Gustav Schonfeld
Robin L Fitzgerald
Zhouji Chen
P2860
P304
14135-14145
P356
10.1074/JBC.M200617200
P407
P577
2002-02-11T00:00:00Z